[
  {
    "entry_id": "map07045",
    "name": "Antineoplastics - protein kinases inhibitors",
    "description": "",
    "classes": [

    ],
    "diseases": {
    },
    "dblinks": {
    },
    "pathways": {
      "map07045": "Antineoplastics - protein kinases inhibitors"
    },
    "orthologs": {
    },
    "references": [
      {
        "authors": [
          "Weisberg E",
          "Manley PW",
          "Breitenstein W",
          "Bruggen J",
          "Cowan-Jacob SW",
          "Ray A",
          "Huntly B",
          "Fabbro D",
          "Fendrich G",
          "Hall-Meyers E",
          "Kung AL",
          "Mestan J",
          "Daley GQ",
          "Callahan L",
          "Catley L",
          "Cavazza C",
          "Azam M",
          "Neuberg D",
          "Wright RD",
          "Gilliland DG",
          "Griffin JD."
        ],
        "title": "Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.",
        "journal": "Cancer Cell 7:129-41 (2005) DOI:10.1016/j.ccr.2005.01.007",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "15710326",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Chow LQ",
          "Eckhardt SG."
        ],
        "title": "Sunitinib: from rational design to clinical efficacy.",
        "journal": "J Clin Oncol 25:884-96 (2007) DOI:10.1200/JCO.2006.06.3602",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "17327610",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Veach DR",
          "Namavari M",
          "Pillarsetty N",
          "Santos EB",
          "Beresten-Kochetkov T",
          "Lambek C",
          "Punzalan BJ",
          "Antczak C",
          "Smith-Jones PM",
          "Djaballah H",
          "Clarkson B",
          "Larson SM."
        ],
        "title": "Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.",
        "journal": "J Med Chem 50:5853-7 (2007) DOI:10.1021/jm070342g",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "17956080",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Debiec-Rychter M",
          "Cools J",
          "Dumez H",
          "Sciot R",
          "Stul M",
          "Mentens N",
          "Vranckx H",
          "Wasag B",
          "Prenen H",
          "Roesel J",
          "Hagemeijer A",
          "Van Oosterom A",
          "Marynen P."
        ],
        "title": "Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.",
        "journal": "Gastroenterology 128:270-9 (2005) DOI:10.1053/j.gastro.2004.11.020",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "15685537",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "von Mehren M."
        ],
        "title": "Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.",
        "journal": "Clin Colorectal Cancer 6 Suppl 1:S30-4 (2006) DOI:10.3816/CCC.2006.s.005",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "17419150",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Guo T",
          "Agaram NP",
          "Wong GC",
          "Hom G",
          "D'Adamo D",
          "Maki RG",
          "Schwartz GK",
          "Veach D",
          "Clarkson BD",
          "Singer S",
          "DeMatteo RP",
          "Besmer P",
          "Antonescu CR"
        ],
        "title": "Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.",
        "journal": "Clin Cancer Res 13:4874-81 (2007) DOI:10.1158/1078-0432.CCR-07-0484",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "17699867",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      }
    ],
    "modules": {
    },
    "organism": "",
    "genes": {
    },
    "enzymes": [

    ],
    "reactions": {
    },
    "compounds": {
      "D01441": "Imatinib mesylate (USAN)",
      "D01977": "Gefitinib (JAN/USAN/INN)",
      "D02714": "Everolimus (JAN/USAN/INN)",
      "D03218": "Axitinib (JAN/USAN)",
      "D03252": "Bosutinib (USAN)",
      "D03257": "Trastuzumab (INN)",
      "D03350": "Canertinib dihydrochloride (USAN)",
      "D03455": "Cetuximab (USAN/INN)",
      "D03658": "Dasatinib (JAN/INN)",
      "D04014": "Enzastaurin hydrochloride (JAN/USAN)",
      "D04023": "Erlotinib hydrochloride (JAN/USAN)",
      "D04024": "Lapatinib ditosylate (USAN)",
      "D04696": "Lestaurtinib (USAN/INN)",
      "D05029": "Midostaurin (USAN/INN)",
      "D05350": "Panitumumab (USAN/INN)",
      "D05380": "Pazopanib hydrochloride (JAN/USAN)",
      "D05446": "Pertuzumab (USAN/INN)",
      "D05819": "Semaxanib (USAN/INN)",
      "D06005": "Tandutinib (USAN/INN)",
      "D06068": "Temsirolimus (JAN/USAN/INN)",
      "D06272": "Sorafenib tosylate (USAN)",
      "D06285": "Vatalanib (USAN/INN)",
      "D06402": "Sunitinib malate (JAN/USAN)",
      "D06407": "Vandetanib (JAN/USAN/INN)",
      "D06413": "Nilotinib hydrochloride hydrate (JAN)",
      "D06414": "Dasatinib (USAN)",
      "D06678": "Motesanib",
      "D07907": "Erlotinib (INN)",
      "D08066": "Imatinib (INN)",
      "D08108": "Lapatinib (INN)",
      "D08524": "Sorafenib (USAN/INN)",
      "D08552": "Sunitinib (INN)",
      "D08947": "Motesanib diphosphate (USAN)",
      "D08953": "Nilotinib (USAN/INN)",
      "D09724": "Afatinib (USAN/INN)",
      "D09728": "Bosutinib hydrate (JAN)",
      "D09731": "Crizotinib (JAN/USAN/INN)",
      "D09733": "Afatinib dimaleate (USAN)",
      "D09955": "Quizartinib (USAN/INN)",
      "D09956": "Quizartinib dihydrochloride (USAN)",
      "D09959": "Ruxolitinib (USAN/INN)",
      "D09960": "Ruxolitinib phosphate (JAN/USAN)",
      "D09980": "Trastuzumab emtansine (USAN/INN)",
      "D10202": "Bafetinib (USAN)"
    },
    "rel_pathways": {
    },
    "ko_pathway": ""
  }
]